Back
Tango Therapeutics, Inc. 10K Form
Sell
29
TNGX
Tango Therapeutics, Inc.
Last Price:
$8.53
Seasonality Move:
-27.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TNGX News And Ratings
See the #1 stock for the next 7 days that we like better than TNGX
TNGX Financial Statistics
Sales & Book Value
| Annual Sales: | $42.1M |
|---|---|
| Cash Flow: | $-31.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.43 |
| Price / Book: | 7.17 |
Profitability
| EPS (TTM): | -0.91650 |
|---|---|
| Net Income (TTM): | $-100.5M |
| Gross Margin: | $39.6M |
| Return on Equity: | -56.44% |
| Return on Assets: | -35.8% |
Tango Therapeutics, Inc. Earnings Forecast
Key Tango Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for TNGX is 94.06%.
-
The Selling, General & Administrative Expenses for TNGX have been equal to 103.99% of Gross Profit Margin.
-
The Research & Development expenses have been 342.10% of Revenue.
-
The Net Earning history of TNGX is -309.73% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Tango Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TNGX |
| Website: | tangotx.com |
Debt
| Debt-to-Equity Ratio: | 0.22 |
|---|---|
| Current Ratio: | 8.88 |
| Quick Ratio: | 8.31 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TNGX Technical Analysis vs Fundamental Analysis
Sell
29
Tango Therapeutics, Inc. (TNGX)
is a Sell
Is Tango Therapeutics, Inc. a Buy or a Sell?
-
Tango Therapeutics, Inc. stock is rated a SellThe current Tango Therapeutics, Inc. [TNGX] share price is $8.52. The Score for TNGX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.